Reaction

Hyperbilirubinaemia Neonatal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 574 reports · 19 co-occurring drugs

As of the last recalculation, Hyperbilirubinaemia Neonatal appears in 574 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is AMPICILLIN (PRR 58.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ampicillin1358.258.3
Ampicillin Sodium1358.258.3
Zidovudine1850.450.4
Atazanavir1538.838.9
Nicotine Polacrilex Mini1537.237.2
Nicotine Polarilex1537.237.2
Tobramycin Solution1030.730.7
Misoprostol830.230.2
Tobramycin Sulfate1029.829.8
Tenofovir Disoproxil Fumarate Tablets729.729.8
Ritonavir 100 Mg1229.729.8
Ritonavir2127.027.0
Levodopa824.324.3
Fosaprepitant Dimeglumine821.421.4
Bleomycin Sulfate621.321.3
Ziprasidone918.818.8
Remdesivir616.516.5
Tobramycin1015.315.3
Nicotine Polacrilex1514.614.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.